UniProt Q29307
ATPase inhibitor, mitochondrial (Q29307)
ATPase inhibitor, mitochondrial (UniProt Q29307): 5 experimental structures and 1 predicted model on GenesisL1, 8 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- Q29307
- Protein
- ATPase inhibitor, mitochondrial
- Experimental structures
- 5
- Predicted models
- 1
- Pockets
- 8 · 2 records with a druggable one
Structures
6 records of Q29307 in the MolNFT archive: 5 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 6J5I | Cryo-EM structure of the mammalian DP-state ATP synthase | electron microscopy | J | — | 4 (best 0.86) |
| 6J5I | Cryo-EM structure of the mammalian dp-state ATP synthase | electron microscopy | J | — | — |
| 6J5J | Cryo-EM structure of the mammalian E-state ATP synthase | electron microscopy | J | — | 4 (best 0.81) |
| 6J5J | Cryo-EM structure of the mammalian E-state ATP synthase | electron microscopy | J | — | — |
| 6J5K | Cryo-EM structure of the mammalian ATP synthase tetramer bound with inhibitory protein IF1 | electron microscopy | J, AJ, BJ, CJ | — | — |
| Q29307 | AlphaFold monomer V2.0 prediction for ATPase inhibitor, mitochondrial (Q29307) | predicted | A | — | — |
Experiment against prediction
- 6J5J chain J against the predicted model Q29307: TM-score 0.72, RMSD 2.37 Å
- 6J5J chain J against the predicted model Q29307: TM-score 0.72, RMSD 2.37 Å
- 6J5I chain J against the predicted model Q29307: TM-score 0.69, RMSD 2.41 Å
- 6J5I chain J against the predicted model Q29307: TM-score 0.69, RMSD 2.41 Å
- 6J5K chain CJ against the predicted model Q29307: TM-score 0.54, RMSD 2.81 Å
- 6J5K chain BJ against the predicted model Q29307: TM-score 0.54, RMSD 2.82 Å
- 6J5K chain AJ against the predicted model Q29307: TM-score 0.54, RMSD 2.34 Å
- 6J5K chain J against the predicted model Q29307: TM-score 0.54, RMSD 2.08 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.